EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical significance of HIF-1α, ET-1, and NO as biomarkers in chronic obstructive pulmonary disease patients with pulmonary hypertension

Xuan Zhang, Youxia Zhou, Huicong Zhang

Biomolecules and Biomedicine · 2024

DOI: 10.17305/bb.2024.11078 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules and Biomedicine, 2024. Verfasst von Xuan Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Respiratory Intensive Care Unit, Hebei Provincial Hospital of Traditional Chinese Medicine, Shijiazhuang, Hebei, China. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Endothelin-1, Hypoxia-Inducible Factor 1, alpha Subunit, Hypertension, Pulmonary. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary hypertension (PH) is a common complication of chronic obstructive pulmonary disease (COPD), with repeated infections and airflow limitation leading to endothelial dysfunction. The objective of this study was to retrospectively investigate the clinical significance of serum hypoxia-inducible factor 1-alpha (HIF-1α), plasma endothelin-1 (ET-1), and nitric oxide (NO) as non-invasive blood biomarkers for diagnosing patients with acute exacerbation of COPD (AECOPD). A total of 230 AECOPD patients were assessed for serum HIF-1α, plasma ET-1, and NO levels using Doppler echocardiography and blood tests. Clinical characteristics, including age, COPD duration, and comorbidities, were compared between patients with and without PH. The diagnostic value was determined through receiver operating characteristic analysis. Pearson correlation and multivariate logistic analyses explored the correlation of biomarkers in AECOPD with PH. Serum HIF-1α, plasma ET-1, and NO levels showed significant differences between COPD patients with and without PH. The combination model (0.027 * HIF-1α + 0.028 * ET-1 − 0.049 * NO) demonstrated an area under the curve of 0.89, indicating superior diagnostic value compared to individual biomarkers. Multivariate logistic analysis identified smoking, higher Global Initiative for Chronic Obstructive Lung Disease grade, hypertension, and elevated levels of HIF-1α, ET-1, and NO as independent risk factors for AECOPD. Positive correlations were observed between serum HIF-1α and plasma ET-1 levels with pulmonary artery systolic pressure, while NO demonstrated a negative correlation. Serum HIF-1α, plasma ET-1, and NO were associated with AECOPD and PH, and detecting individual or combined levels of these biomarkers in the blood can predict COPD-related PH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveEndothelin-1Hypoxia-Inducible Factor 1, alpha SubunitHypertension, PulmonaryNitric OxideHumansMaleFemaleBiomarkersAgedMiddle AgedRetrospective StudiesClinical Relevance

Substanzen

Endothelin-1Hypoxia-Inducible Factor 1, alpha SubunitBiomarkersNitric OxideHIF1A protein, human

Autor:innen und Institutionen

  • Respiratory Intensive Care Unit, Hebei Provincial Hospital of Traditional Chinese Medicine, Shijiazhuang, Hebei, China.
  • Department of General Internal Medicine, Shijiazhuang Fourth Hospital, Shijiazhuang, Hebei, China.
  • Respiratory Department, Hebei Provincial Hospital of Traditional Chinese Medicine, Shijiazhuang, Hebei, China.

Zitieren

APA

Zhang, X., Zhou, Y., & Zhang, H. (2024). Clinical significance of HIF-1α, ET-1, and NO as biomarkers in chronic obstructive pulmonary disease patients with pulmonary hypertension. Biomolecules and Biomedicine. https://doi.org/10.17305/bb.2024.11078

Vancouver

Zhang X, Zhou Y, Zhang H. Clinical significance of HIF-1α, ET-1, and NO as biomarkers in chronic obstructive pulmonary disease patients with pulmonary hypertension. Biomolecules and Biomedicine. 2024. doi:10.17305/bb.2024.11078

BibTeX
@article{Zhang2024,
  author = {Zhang, Xuan and Zhou, Youxia and Zhang, Huicong},
  title = {Clinical significance of HIF-1α, ET-1, and NO as biomarkers in chronic obstructive pulmonary disease patients with pulmonary hypertension},
  journal = {Biomolecules and Biomedicine},
  year = {2024},
  doi = {10.17305/bb.2024.11078}
}
Kostenlos starten →